British Heart Foundation

The British Heart Foundation was founded in 1961 by a group of medical professionals who were concerned about the increasing death rate from cardiovascular disease. They wanted to fund extra research into the causes, diagnosis, treatment, and prevention of heart and circulatory diseases. ==Leadership==

Dr Charmaine Griffiths has been the BHF's Chief Executive since February 2020, succeeding Simon Gillespie OBE. Professor Bryan Williams OBE became the charity's first Chief Scientific and Medical Officer (CSMO) in December 2023, after Professor Sir Nilesh Samani stood down as Medical Director after more than 7 years in the role. The BHF's Board of Trustees is made up of up to 14 Trustees, and is a mix of medically-qualified and lay members: ==Activities==

The British Heart Foundation's main focus is to fund cardiovascular research, aiming to spend around £100 million a year funding scientists around the UK. They are currently funding over 1000 research projects. Centres of Research Excellence Since 2008 the BHF has been investing in Centres of Research Excellence. The eight current centres bring together scientists from a number of disciplines to work on research projects to beat heart and circulatory disease. The current Centres of Research are: • University of Cambridge • University College London • University of Edinburgh • Imperial College London • King's College London • University of Leicester • University of Oxford • University of Manchester Centres of Regenerative Medicine In 2013 the BHF committed to funding three multi-institution Centres of Regenerative Medicine, investing £7.5 million over four years to fund scientists looking for new treatments for heart failure. BHF Clinical Research Collaborative The British Heart Foundation Clinical Research Collaborative was launched in 2019, hosted by the British Cardiovascular Society. Designed to support the planning of high-quality national cardiovascular research, it brings together professional societies, research groups and patient and public involvement to better coordinate and prioritise research efforts. and is working with the Department of Health to distribute defibrillators throughout England. In 2020, The British Heart Foundation had a net income of just over £107m. In the same year, the BHF spent over £93m on funding cardiovascular research. The Global Cardiovascular Research Funders Forum The charity announced, in June 2021, that it had joined forces with leading cardiovascular research funders around the world to form the Global Cardiovascular Research Funders Forum (GCRFF). In addition to the British Heart Foundation, the Forum's members are: • The American Heart Association • (The Danish Heart Foundation) • (The Dutch Heart Foundation) • (The Swiss Heart Foundation) • (German Centre for Cardiovascular Research: DZHK) • The Leducq Foundation • The Heart and Stroke Foundation of Canada • The Canadian Institutes of Health Research • The National Heart Foundation of Australia • The National Heart Foundation of New Zealand • The National Heart, Lung, and Blood Institute (NHLBI) The Big Beat Challenge was open to applications from any country globally, and accepted proposals in any research area related to cardiovascular disease. Based on a panel of BHF research-funding committee members and an International Advisory panel, a shortlist was finalised in January 2020 to include a robotic heart, a 'Google map' of atherosclerosis, a project harnessing artificial intelligence (AI) and wearables to create a cardiovascular digital twin of a patient, and a genetic cure for inherited heart conditions. CureHeart, led by co-PIs Professor Hugh Christian Watkins and Professor Christine Seidman, which aims to find a cure for genetic cardiomyopathies, was announced as the winner of the Big Beat Challenge in July 2022. Fundraising BHF fundraising events accounted for nearly £54m of income in 2019-20. The BHF won the bid to be named as the London Marathon charity partner for the 2022 raise, aiming to raise £3m through the partnership to invest in clinical research. The annual London to Brighton Bike Ride is a flagship fundraising event, with over 16,000 cyclists and raising over £2.8m. The event was cancelled in 2020 and 2021, and was expected to return in 2022 with PureGym as the sponsor. As of 2021, they run around 730 shops which include over 160 furniture and electrical shops selling up to 85,000 items daily. The BHF Retail division makes roughly £30 million every year. ==Facts and figures==

• Since the BHF was established, the annual number of deaths from heart and circulatory diseases in the UK has fallen by around half. • Heart and circulatory diseases cause a quarter of all deaths in the UK, totally around 160,000 deaths. • Every year, 1 in every 145 babies are born in the UK with a congenital heart defect. ==Criticism==

Animal research In June 2011, the British Heart Foundation was one of several health charities, alongside Cancer Research UK, the Alzheimer's Society and Parkinson's UK, targeted by animal rights pressure group Animal Aid, in a series of newspaper advertisements urging the public not to donate to the organizations under the pretence of funding experiments on animals. The pressure group argued that 100 dogs had died since 1988 during the experiments. The BHF has responded to these criticisms by saying the charity only funds animal research after grant applications have gone through an independent peer review process and follows the three Rs principles when considering such grants. Wealth screening In 2016, the BHF was fined by the UK Information Commissioner's Office which ruled that the charity had breached data protection legislation by employing external bodies to analyse the financial status of supporters in order to appeal to them for further donations, a practice known as 'wealth screening'. BBC News Online reported that, "Information Commissioner Elizabeth Denham said donors had not been informed of the charity's practices, and were therefore unable to consent or object to them." She suggested other charities could also be engaged in similar activities. The charity's chief executive stated that "The ICO's conclusions were 'wrong, disproportionate and inconsistent […] We find the decision surprising, as earlier this year in June the ICO praised our data handling. Our trustees will therefore consider whether it's in the interests of our supporters and beneficiaries to challenge this decision." ==See also==